Beijing-based Pharmaron has secured support from the UK government to expand its viral vector and DNA manufacturing facilities in Speke, Liverpool. The firm’s UK-based subsidiary, Gene Therapy CDMO, has received a grant from the Life Sciences Innovation Manufacturing Fund. The
Thank you for reading EG
Want to read more? Enjoy a story a week for FREE for one month.
Register
Find Out More